We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$21.6M
2
TCOM icon
Trip.com Group
TCOM
+$20.5M
3
AOD
abrdn Total Dynamic Dividend Fund
AOD
+$12.1M
4
GDV icon
Gabelli Dividend & Income Trust
GDV
+$12M
5
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
+$11.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAHC icon
1026
Phibro Animal Health
PAHC
$1.39B
$11K ﹤0.01%
460
-5
-1% -$113
RNAC icon
1027
Cartesian Therapeutics
RNAC
$268M
$11K ﹤0.01%
82
-1
-1% -$124
SIGA icon
1028
SIGA Technologies
SIGA
$219M
$11K ﹤0.01%
1,790
-85
-5% -$576
SMMT icon
1029
Summit Therapeutics
SMMT
$11.1B
$11K ﹤0.01%
1,905
-130
-6% -$839
TXMD icon
1030
TherapeuticsMD
TXMD
$24M
$11K ﹤0.01%
176
+35
+25% +$2.74K
XBIT icon
1031
XBiotech
XBIT
$69.2M
$11K ﹤0.01%
665
-5
-0.7% -$93
TECX
1032
Tectonic Therapeutic
TECX
$606M
$11K ﹤0.01%
78
-1
-1% -$163
ANIP icon
1033
ANI Pharmaceuticals
ANIP
$1.78B
$10K ﹤0.01%
280
-5
-2% -$157
APLT
1034
DELISTED
Applied Therapeutics
APLT
$10K ﹤0.01%
580
+65
+13% +$1.4K
INZY
1035
DELISTED
Inozyme Pharma
INZY
$10K ﹤0.01%
530
-5
-0.9% -$110
META icon
1036
Meta Platforms (Facebook)
META
$1.51T
$10K ﹤0.01%
36
+24
+200% +$6.46K
SYRS
1037
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$10K ﹤0.01%
140
+35
+33% +$3.64K
FUSN
1038
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$10K ﹤0.01%
945
-10
-1% -$117
GMDA
1039
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$10K ﹤0.01%
1,350
+175
+15% +$1.61K
BCEL
1040
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$10K ﹤0.01%
680
-10
-1% -$162
ORTX
1041
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$10K ﹤0.01%
139
-1
-0.7% -$71
SPPI
1042
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$10K ﹤0.01%
3,335
-65
-2% -$233
JNCE
1043
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$10K ﹤0.01%
1,030
+85
+9% +$931
AKUS
1044
DELISTED
Akouos Inc
AKUS
$10K ﹤0.01%
775
-15
-2% -$273
LKFT
1045
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$9K ﹤0.01%
120
-35
-23% -$3.22K
KALA icon
1046
KALA BIO
KALA
$14.5M
$9K ﹤0.01%
1
– –
SPRO icon
1047
Spero Therapeutics
SPRO
$73M
$9K ﹤0.01%
620
-5
-0.8% -$88
URGN icon
1048
UroGen Pharma
URGN
$2.29B
$9K ﹤0.01%
495
-10
-2% -$212
VSTM icon
1049
Verastem
VSTM
$610M
$9K ﹤0.01%
323
-2
-0.6% -$56
XYF
1050
X Financial
XYF
$204M
$9K ﹤0.01%
2,595
+1,730
+200% +$5.41K
40 41
42
43 44

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.